Region — US. Neutral scientific reference — not offered for sale here.
Set region
Vallydia
ExploreShopToolsJournalTrustSearch ⌕
Explore  /  Oxytocin
Research reference — not for sale

Oxytocin

A
lead outcome
Labor induction / uterotonic / postpartum…
grades vary by outcome ↓
Peptide
also called — Oxytocin · OXT · trade names Pitocin (IV/IM), Syntocinon (nasal, outside US)
(approved:) labor induction / uterotoniclactation(investigational/hyped:) social bonding / trust / empathyautismanxiety / PTSD / addiction

The "love hormone" — approved for childbirth, hyped for everything social, and a textbook replication-crisis story. Oxytocin is a real, approved drug and one of the most over-hyped molecules in popular science. Three threads: (1) as Pitocin, synthetic oxytocin is a genuinely FDA-approved obstetric d

In brief

Oxytocin is a 9-amino-acid endogenous hormone with two lives. As a peripheral hormone, it drives uterine contraction and milk let-down — and synthetic oxytocin (Pitocin) is a genuinely FDA-approved obstetric drug for labor induction and postpartum bleeding. As a central neurotransmitter, it shapes maternal and social bonding — which made it famous as the "love/trust/cuddle hormone." That fame outran the data: many marquee human findings (oxytocin boosting trust or empathy/"mind-reading") failed to replicate, and oxytocin became a symbol of the replication crisis. Its biggest therapeutic hope, autism, has largely disappointed — the large SOARS-B trial found no benefit, and a 2022 NEJM editorial summed it up as "down, but not out." Add genuine uncertainty about how much intranasal oxytocin even reaches the brain, and the honest picture is: a real, important, approved hormone for childbirth — and a much-hyped, inconsistently-supported one for the social/emotional uses it's mostly sold and celebrated for. Big, real biology; approved for one thing; oversold for another.

Legal standing, by region
European Union
Approved / prescription

approved as an obstetric drug (oxytocin/carbetocin); Syntocinon nasal spray available in some countries; social/psychiatric uses investigational.

United States · your region
Approved / prescription

FDA-approved as Pitocin (IV/IM) for obstetric use; the nasal spray is not currently marketed in the US (withdrawn 1995). Intranasal oxytocin for social/psychiatric uses is investigational / off-label / compounded.

Evidence, by outcome

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Labor induction / uterotonic / postpartum hemorrhage (the approved use)
Real, established medicine — but a hospital obstetric drug, nothing to do with the "bonding" uses it's sold for; misuse is dangerous
FDA-approved (Pitocin); decades of obstetric use; clear OTR→myometrial-contraction mechanism
A
Lactation / milk let-down
Withdrawn in US for commercial (not efficacy) reasons; still used in some countries
Historically approved (Syntocinon nasal)
B
Social bonding / trust / empathy (healthy people — the "love hormone" claims)
The replication-crisis core: early trust/"mind-reading" results didn't hold up; underpowered studies + publication bias
Strong animal data; human findings largely failed to replicate; effect sizes small
D
Autism spectrum disorder (social deficits)
"Down, but not out" — inconsistent, unreplicated; possible subgroup/dose signals unproven
Decades of RCTs; SOARS-B (large, Phase 2): no benefit; meta-analyses heterogeneous (I²≈93%)
D
PTSD / anxiety / addiction / social anxiety
Early, mixed; nothing established
Preliminary human studies
F
Safety
Obstetric IV: risk of uterine hyperstimulation, fetal distress, water intoxication at high/prolonged doses. Intranasal in trials: generally well-tolerated short-term; brain delivery uncertain
Extensive obstetric + research exposure

Identity a 9-amino-acid cyclic peptide (with a disulfide bridge) that is both a hormone and a central neurotransmitter. It's made in the hypothalamus, stored in and released from the posterior pituitary, and acts through the oxytocin receptor (OTR), a Gq-coupled GPCR. It has two quite separate lives: a peripheral hormonal role (uterine contraction, milk let-down) and a central neuromodulatory role (social/maternal behavior) — and the register distinction between them is essential, because the peripheral role is approved medicine and the central one is mostly hype-outpacing-evidence. (Historically notable: oxytocin was the first peptide hormone ever chemically synthesized — du Vigneaud, Nobel Prize 1955.) ## Mechanism (as proposed) oxytocin acts through the oxytocin receptor (OTR), a Gq/11-coupled GPCR signalling via phospholipase C → IP3 → intracellular Ca²⁺. Peripherally, in the myometrium, this Ca²⁺ rise (plus prostaglandin production) drives uterine contraction — the basis of its labor-inducing action; OTR density rises dramatically toward term (why it works then). It also contracts mammary myoepithelial cells for milk let-down. Centrally, oxytocin released within the brain modulates amygdala, reward, and social-cognition circuits, influencing maternal behavior, pair-bonding, social salience, and fear/trust processing — robustly in animal models. The translational problem is that central human effects are small, context-/genotype-dependent (OXTR variants), and inconsistently replicated, and intranasal delivery to the brain is itself uncertain — so the elegant "give oxytocin → more bonding/less social deficit" logic hasn't reliably materialized in human trials.

Sources — 4 cited
01FDA labeling — oxytocin (Pitocin) for labor induction/augmentation and postpartum hemorrhage; Syntocinon nasal (milk let-down, US withdrawal 1995).
02Replication-crisis literature: failures to replicate intranasal-oxytocin effects on trust and mind-reading in healthy adults; underpowering/publication-bias critiques (e.g. Scientific Reports 2021).
03Autism: SOARS-B (Sikich et al., NEJM 2021) — no benefit; NEJM editorial 2022 "down, but not out"; meta-analyses (Front Psychiatry 2025, I²≈93%); Current Opinion in Neurobiology 2025 review (no consistent clinical benefit).
04Mechanism/obstetrics reviews (OTR/Gq/PLC/Ca²⁺, myometrium); du Vigneaud synthesis (Nobel 1955). (Social/psychiatric uses investigational; not approved.)
Review status
Not yet reviewed

A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated July 2026 (watch: OXTR-genotype-stratified / precision-medicine trials and any dose/subgroup autism signal — the field's remaining hope after SOARS-B).

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
VIP (Vasoactive Intestinal Peptide)A
Peptide
Kisspeptin-10 (KP-10)B
Peptide
PT-141 (Bremelanotide)B
Peptide
Afamelanotide (Scenesse / Melanotan-1)A
Peptide
Melanotan IIC
Peptide
Explore by goal
Neuro & cognitiveAnti-inflammatorySleep & circadianReproductiveSkin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.

Region — United States
ExploreRegisterCategoriesTrust & COA
ShopCosmetic peptidesJournal
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.

Oxytocin — the "love hormone": approved for labor, unproven for bonding/autism, and the replication story · Vallydia